Glutamine supplementation to critically ill patients?

Critical Care

Volumn 18, Issue 2, 2014, Pages

  Wernerman, Jan ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTAMINE;

ACUTE ON CHRONIC LIVER FAILURE; APACHE; BLOOD LEVEL; CLINICAL STUDY; CRITICALLY ILL PATIENT; ENTERIC FEEDING; HUMAN; INTENSIVE CARE UNIT; KIDNEY FAILURE; LIVER FAILURE; MORTALITY; NUTRITIONAL SUPPORT; PARENTERAL NUTRITION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SEQUENTIAL ORGAN FAILURE ASSESSMENT SCORE; TREATMENT DURATION; VITAMIN SUPPLEMENTATION; ADVERSE EFFECTS; CRITICAL ILLNESS; DIET SUPPLEMENTATION; PROCEDURES; TRENDS;

CRITICAL ILLNESS; DIETARY SUPPLEMENTS; ENTERAL NUTRITION; GLUTAMINE; HUMANS; MORTALITY;

EID: 84897398767     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc13781     Document Type: Review

References (31)

1. Heyland D, Muscedere J, Wischmeyer PE, Cook D, Jones G, Albert M, Elke G, Berger MM, Day AG, Canadian Critical Care Trials Group A randomized trial of glutamine and antioxidants in critically ill patients. N Engl J Med 2013, 368:1489-1497. 10.1056/NEJMoa1212722, 23594003, Canadian Critical Care Trials Group.
2. Bollhalder L, Pfeil AM, Tomonaga Y, Schwenkglenks M. A systematic literature review and meta-analysis of randomized clinical trials of parenteral glutamine supplementation. Clin Nutr 2013, 32:213-223. 10.1016/j.clnu.2012.11.003, 23196117.
3. Novak F, Heyland DK, Avenell A, Drover JW, Su X. Glutamine supplementation in serious illness: a systematic review of the evidence. Crit Care Med 2002, 30:2022-2029. 10.1097/00003246-200209000-00011, 12352035.
4. Oudemans-van Straaten HM, Bosman RJ, Treskes M, van der Spoel HJ, Zandstra DF. Plasma glutamine depletion and patient outcome in acute ICU admissions. Intensive Care Med 2001, 27:84-90. 10.1007/s001340000703, 11280678.
5. Rodas PC, Rooyackers O, Hebert C, Norberg A, Wernerman J. Glutamine and glutathione at ICU admission in relation to outcome. Clin Sci (Lond) 2012, 122:591-597. 10.1042/CS20110520, 3294430, 22248298.
6. Ekmark L, Rooyackers O, Werneman J, Flaring U. Plasma glutamine correlates with multiple organ failure in critically ill children. Clin NutrSuppl 2009, 4:174.
7. Clemmesen JO, Kondrup J, Ott P. Splanchnic and leg exchange of amino acids and ammonia in acute liver failure. Gastroenterology 2000, 118:1131-1139. 10.1016/S0016-5085(00)70366-0, 10833488.
8. Berg A, Rooyackers O, Norberg A, Wernerman J. Elimination kinetics of L-alanyl-L-glutamine in ICU patients. Amino Acids 2005, 29:221-228. 10.1007/s00726-005-0230-9, 16049639.
9. Tjader I, Rooyackers O, Forsberg AM, Vesali RF, Garlick PJ, Wernerman J. Effects on skeletal muscle of intravenous glutamine supplementation to ICU patients. Intensive Care Med 2004, 30:266-275. 10.1007/s00134-003-2048-9, 14722645.
10. Houdijk AP, Rijnsburger ER, Jansen J, Wesdorp RI, Weiss JK, McCamish MA, Teerlink T, Meuwissen SG, Haarman HJ, Thijs LG, van Leeuwen P. Randomised trial of glutamine-enriched enteral nutrition on infectious morbidity in patients with multiple trauma. Lancet 1998, 352:772-776. 10.1016/S0140-6736(98)02007-8, 9737282.
11. Dechelotte P, Darmaun D, Rongier M, Hecketsweiler B, Rigal O, Desjeux J. Absorption and metabolic effects of enterally administered glutamine in humans. Am J Physiol 1991, 260:G677-G682.
12. Melis GC, Boelens PG, van der Sijp JR, Popovici T, De Bandt JP, Cynober L, van Leeuwen P. The feeding route (enteral or parenteral) affects the plasma response of the dipeptide Ala-Gln and the amino acids glutamine citrulline and arginine with the administration of Ala-Gln in preoperative patients. Br J Nutr 2005, 94:19-26. 10.1079/BJN20051463, 16115328.
13. Darmaun D, Matthews DE, Bier D. Glutamine and glutamate kinetics in humans. Am J Physiol 1986, 251:E117-E126.
14. Matthews DE, Marano MA, Campbell R. Splanchnic bed utilization of glutamine and glutamic acid in humans. Am J Physiol 1993, 264:E848-E854.
15. Rooyackers O, Prohn M, Van Riel N, Wernerman J. Bolus injection on 13 C-glutamine to study glutamine metabolism in humans. Clin Nutr 2005, 24:575-576.
16. van Acker BA, Hulsewe KW, Wagenmakers AJ, Soeters PB, von Meyenfeldt MF. Glutamine appearance rate in plasma is not increased after gastrointestinal surgery in humans. J Nutr 2000, 130:1566-1571.
17. van Acker BA, Hulsewe KW, Wagenmakers AJ, von Meyenfeldt MF, Soeters P. Response of glutamine metabolism to glutamine-supplemented parenteral nutrition. Am J Clin Nutr 2000, 72:790-795.
18. Goeters C, Wenn A, Mertes N, Wempe C, Van Aken H, Stehle P, Bone H. Parenteral L-alanyl-L-glutamine improves 6-month outcome in critically ill patients. Crit Care Med 2002, 30:2032-2037. 10.1097/00003246-200209000-00013, 12352037.
19. Griffiths RD, Jones C, Palmer T. Six-month outcome of critically ill patients given glutamine-supplemented parenteral nutrition. Nutrition 1997, 13:295-302.
20. McClave SA, Martindale RG, Vanek VW, McCarthy M, Roberts P, Taylor B, Ochoa JB, Napolitano L, Cresci G, ASPEN Board of Directors, American College of Critical Care Medicine, Society of Critical Care Medicine Guidelines for the provision and assessment of nutrition support therapy in the adult critically ill patient: Society of Critical Care Medicine (SCCM) and American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.). JPEN J Parenter Enteral Nutr 2009, 33:277-316. 10.1177/0148607109335234, 19398613, ASPEN Board of Directors, American College of Critical Care Medicine, Society of Critical Care Medicine.
21. Singer P, Berger MM, Van den Berghe G, Biolo G, Calder P, Forbes A, Griffiths R, Kreyman G, Leverve X, Pichard C, ESPEN ESPEN Guidelines on Parenteral Nutrition: intensive care. Clin Nutr 2009, 28:387-400. 10.1016/j.clnu.2009.04.024, 19505748, ESPEN.
22. Kreymann KG, Berger MM, Deutz NE, Hiesmayr M, Jolliet P, Kazandjiev G, Nitenberg G, van den Berghe G, Wernerman J, Ebner C, Hartl W, Heymann C, Spies C, DGEM (German Society for Nutritional Medicine), ESPEN (European Society for Paternal and Enteral Nutrition) ESPEN Guidelines on Enteral Nutrition: Intensive care. Clin Nutr 2006, 25:210-223. 10.1016/j.clnu.2006.01.021, 16697087, DGEM (German Society for Nutritional Medicine), ESPEN (European Society for Paternal and Enteral Nutrition).
23. Doig GS, Heighes PT, Simpson F, Sweetman EA, Davies A. Early enteral nutrition provided within 24 h of injury or intensive care unit admission significantly reduces mortality in critically ill patients: a meta-analysis of randomised controlled trials. Intensive Care Med 2009, 35:2018-2027. 10.1007/s00134-009-1664-4, 19777207.
24. Heyland DK, MacDonald S, Keefe L, Drover J. Total parenteral nutrition in the critically ill patient: a meta-analysis. JAMA 1998, 280:2013-2019. 10.1001/jama.280.23.2013, 9863853.
25. Doig GS, Heighes PT, Simpson F, Sweetman E. Early enteral nutrition reduces mortality in trauma patients requiring intensive care: a metaanalysis of randomised controlled trials. Injury 2011, 42:50-56. 10.1016/j.injury.2010.06.008, 20619408.
26. Preiser JC, Wernerman J. REDOXS: Important answers many more questions raised!. JPEN J Parenter Enteral Nutr 2013, 37:566-567. 10.1177/0148607113495893, 24005912.
27. Andrews PJ, Avenell A, Noble DW, Campbell MK, Croal BL, Simpson WG, Vale LD, Battison CG, Jenkinson DJ, Cook JA, Scottish Intensive care Glutamine or seleNium Evaluative Trial Trials Group Randomised trial of glutamine selenium or both to supplement parenteral nutrition for critically ill patients. BMJ 2011, 342:d542. Scottish Intensive care Glutamine or seleNium Evaluative Trial Trials Group.
28. Pytlik R, Benes P, Patorkova M, Chocenská E, Gregora E, Procházka B, Kozák T. Standardized parenteral alanyl-glutamine dipeptide supplementation is not beneficial in autologous transplant patients: a randomized doubleblind placebo controlled study. Bone Marrow Transplant 2002, 30:953-961. 10.1038/sj.bmt.1703759, 12476290.
29. Moreno R, Vincent JL, Matos R, Mendonça A, Cantraine F, Thijs L, Takala J, Sprung C, Antonelli M, Bruining H, Willatts S. The use of maximum SOFA score to quantify organ dysfunction/failure in intensive care. Results of a prospective multicentre study. Working Group on Sepsis related Problems of the ESICM. Intensive Care Med 1999, 25:686-696. 10.1007/s001340050931, 10470572.
30. Amodio P, Bemeur C, Butterworth R, Cordoba J, Kato A, Montagnese S, Ribe M, Vilstrup H, Morgan M. The nutritional management of hepatic encephalopathy in patients with cirrhosis: International Society for Hepatic Encephalopathy and Nitrogen Metabolism Consensus. Hepatology 2013, 58:325-336. 10.1002/hep.26370, 23471642.
31. Wernerman J, Kirketeig T, Andersson B, Berthelson H, Ersson A, Friberg H, Guttormsen AB, Hendriks S, Pettilä V, Rossi P, Sjoberg F, Winso O, Scandinavian Critical Care Trials Group Scandinavian glutamine trial: a pragmatic multicentre randomised clinical trial of intensive care unit patients. Acta AnaesthesiolScand 2011, 55:812-818. Scandinavian Critical Care Trials Group.